Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC)

Price 123.00p on 29-03-2024 at 04:45:11
Change 0.00p 0%
Buy 122.80p
Sell 122.20p
Buy / Sell SYNC Shares
Last Trade: Unknown 55.00 at 123.012p
Day's Volume: 0
Last Close: 123.00p
Open: 0.00p
ISIN: GG00B8P59C08
Day's Range 0.00p - 0.00p
52wk Range: 105.00p - 162.20p
Market Capitalisation: £806m
VWAP: 0.00p
Shares in Issue: 656m

Recent Trades History Syncona (SYNC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 55 123.012p Currency Conversion
OTC Trade
17:53:56 - 28-Mar-24
Buy* 13,996 123.00p Ordinary
16:37:13 - 28-Mar-24
Buy* 141,576 123.00p Suspected BUY Trade
16:35:07 - 28-Mar-24
Sell* 216 122.20p Automatic Execution
16:29:42 - 28-Mar-24
Buy* 4 122.80p SI Trade
16:28:48 - 28-Mar-24
Sell* 22,280 122.3861p Ordinary
16:13:25 - 28-Mar-24
Buy* 2,000 122.88p Ordinary
16:10:29 - 28-Mar-24
Unknown* 2 122.20p SI Trade
Currency Conversion
16:02:33 - 28-Mar-24
Sell* 4 122.20p Automatic Execution
15:47:35 - 28-Mar-24
Buy* 3,842 122.8775p Ordinary
15:47:00 - 28-Mar-24

Share Price History for Syncona

Time period:
to
Date Open High Low Close Volume

Share News for Syncona

Syncona portfolio company Autolus posts widened loss for 2023

14th Mar 2024 14:16

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an increase in annual expenses. Read More

IN BRIEF: Freeline shareholders approve Syncona acquisition

12th Feb 2024 18:01

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona. Read More

UPDATE: Syncona portfolio strengthens thanks to Autolus

8th Feb 2024 13:45

(Alliance News) - Syncona Ltd on Thursday said its portfolio company Autolus Therapeutics PLC has struck a deal to work with BioNTech to commercialise its CAR-T programmes. Read More

Syncona portfolio strengthens in third quarter thanks to Autolus

8th Feb 2024 09:41

(Alliance News) - Syncona Ltd on Thursday reported a recent increase to the value of its portfolio, as the company said it was in a strong position to push forward its main life science companies. Read More

IN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-cel

22nd Jan 2024 12:19

Syncona Ltd - London-based investor in healthcare companies - The US Food & Drug Administration accepts Autolus Therapeutics PLC's biologics licence application for obe-cel for patients with relapsed/refractory adult B-cell acute lymphoblastic leukaemia. The FDA has set a target action date of November 16 for reviewing the application, Syncona says. Further, Autolus is on track to submit a marketing authorisation application to the EU's European Medicines Agency in the first half of 2024. Read More

FTSE 100 Latest
Value7,952.62
Change0.00

Login to your account

Forgot Password?

Not Registered